RxOUTMAP tracks and quantifies the impact of pharmacist management of patients with uncomplicated urinary tract infections.
Urinary tract infections (UTIs) are common infections that may be very unpleasant for patients and have the potential to lead to complications. They are also commonly misdiagnosed and treated inappropriately, resulting in unnecessary antimicrobial exposure and increased potential for adverse effects (including secondary infections, such as Clostridium difficile), as well as the selection of resistant pathogens. With increasing rates of bacterial resistance and a limited pipeline of antibacterials with novel mechanisms of action, antimicrobial stewardship has become imperative to maintain the effectiveness of available antimicrobials. Pharmacists are accessible primary care professionals that are well-positioned to take on a larger role in the management of medical conditions, including UTIs, and have an important role to play in antimicrobial stewardship. Therefore, the purpose of this study is to quantify the real-world impact of pharmacists assessing and managing (including prescribing for) the care of patients with uncomplicated UTI.
- RxOUTMAP (UTI Registry) Protocol
- RxOUTMAP (UTI Registry) Study Information and Consent Forms
- RxOUTMAP (UTI Registry) Database Instructions
- RxOUTMAP (UTI Registry) Investigators’ Meeting